| Mechanisms of human FoxP3+ Treg cell development and function in health and disease M Attias, T Al-Aubodah, CA Piccirillo Clinical & experimental immunology 197 (1), 36-51, 2019 | 89 | 2019 |
| Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses F Huang, C Gonçalves, M Bartish, J Rémy-Sarrazin, ME Issa, B Cordeiro, ... The Journal of clinical investigation 131 (8), 2024 | 58 | 2024 |
| Materno-fetal transfer of preproinsulin through the neonatal Fc receptor prevents autoimmune diabetes S Culina, N Gupta, R Boisgard, G Afonso, MC Gagnerault, J Dimitrov, ... Diabetes 64 (10), 3532-3542, 2015 | 36 | 2015 |
| Enhanced anticancer effect of a combination of S-adenosylmethionine (SAM) and immune checkpoint inhibitor (ICPi) in a syngeneic mouse model of advanced melanoma A Mehdi, M Attias, N Mahmood, A Arakelian, C Mihalcioiu, CA Piccirillo, ... Frontiers in Oncology 10, 1361, 2020 | 20 | 2020 |
| The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors M Attias, CA Piccirillo British Journal of Pharmacology, 2024 | 8 | 2024 |
| S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas A Mehdi, M Attias, A Arakelian, M Szyf, CA Piccirillo, SA Rabbani Neoplasia 36, 100874, 2023 | 8 | 2023 |
| Co-targeting luminal B breast cancer with S-Adenosylmethionine and immune checkpoint inhibitor reduces primary tumor growth and progression, and metastasis to lungs and bone A Mehdi, M Attias, A Arakelian, CA Piccirillo, M Szyf, SA Rabbani Cancers 15 (1), 48, 2022 | 7 | 2022 |
| Anti-PD-1 amplifies costimulation in melanoma-infiltrating Th1-like Foxp3+ regulatory T cells to alleviate local immunosuppression M Attias, F Alvarez, TA Al-Aubodah, R Istomine, P McCallum, F Huang, ... Journal for ImmunoTherapy of Cancer 13 (1), e009435, 2025 | | 2025 |
| Dissecting the Consequences of PD-1 Blockade on the Functional Adaptations of Regulatory T cells in Melanoma M Attias McGill University, 2024 | | 2024 |
| The MNK1/2-eIF4E axis drives melanoma plasticity, progression, and resistance to immunotherapy F Huang, C Gonçalves, M Bartish, J Rémy-Sarrazin, Q Guo, A Emond, ... bioRxiv, 2020.05. 29.117531, 2020 | | 2020 |
| Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses F Huang, C Gonçalves, M Bartish, J Rémy-Sarrazin, ME Issa, B Cordeiro, ... | | |
